Bio-Rad Laboratories, Inc. (BIO)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 549.12 |
| Open | 553.89 |
| Bid | 399.98 x 1100 |
| Ask | 547.05 x 800 |
| Day's range | 542.32 - 556.32 |
| 52-week range | 462.61 - 832.70 |
| Volume | |
| Avg. volume | 173,056 |
| Market cap | 16.411B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 2.49 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up
Overall demand for Bio-Rad's (BIO) Life Science and Clinical Diagnostics continues to be strong on localized surges of COVID-19.
- Zacks
Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings and Revenue Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 37.40% and 3.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Medical Device Stocks to Watch for Earnings on Jul 28
Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, TMO and BIO will likely fare this time.
© 2022 Yahoo. All rights reserved.
